0
0.5
1
1.5
2+
Mortality
42%
Improvement
Relative Risk
Remdesivir for COVID-19 Raad et al. LATE TREATMENT
Is late treatment with remdesivir beneficial for COVID-19?
Retrospective study in multiple countries (January - November 2020)
Lower mortality with remdesivir (p=0.009)
c19early.org
Raad et al., medRxiv, August 2022
Favors remdesivir
Favors control